P948: INCIDENCE AND CLINICAL OUTCOME OF SARS-COV-2 INFECTION AFTER VACCINATION IN PATIENTS WITH MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE (MGUS)

P948: INCIDENCE AND CLINICAL OUTCOME OF SARS-COV-2 INFECTION AFTER VACCINATION IN PATIENTS WITH MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE (MGUS)

Bibliographic Details
Main Authors:	N. Sgherza, P. Curci, R. Rizzi, D. Roccotelli, M. Croce, M. Avantaggiato, L. Ruga, A. Vitucci, A. Palma, D. Di Gennaro, P. Musto
Format:	Article
Language:	English
Published:	Wiley 2022-06-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000846660.15920.42

Similar Items

P29: EFFECTS OF VACCINATION ON INCIDENCE AND OUTCOME OF SARS-COV-2 INFECTION IN PATIENTS WITH MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE (MGUS)
by: N Sgherza, et al.
Published: (2022-04-01)

SARS-CoV-2 Infection Incidence and Outcome Before and After Full Vaccination in Patients With Monoclonal Gammopathy of Undetermined Significance
by: Nicola Sgherza, et al.
Published: (2022-12-01)

Humoral immune response after anti-SARS-CoV-2 vaccine “booster” dose in patients with monoclonal gammopathy of undetermined significance (MGUS)
by: NICOLA SGHERZA, et al.
Published: (2023-01-01)

Monoclonal Gammopathy of Undetermined Significance (MGUS)—Not So Asymptomatic after All
by: Oliver C. Lomas, et al.
Published: (2020-06-01)

Low knowledge and awareness of monoclonal gammopathy of undetermined significance (MGUS) among general practitioners
by: Charlene M. McShane, et al.
Published: (2019-05-01)

Body mass index associated with monoclonal gammopathy of undetermined significance (MGUS) progression in Olmsted County, Minnesota
by: Geffen Kleinstern, et al.
Published: (2022-04-01)

The “Undetermined Significance” of <sup>18</sup>F-FDG PET/CT or PET/MRI in Patients with Monoclonal Gammopathy of Undetermined Significance (MGUS)
by: Giorgio Treglia, et al.
Published: (2021-08-01)

Monoclonal gammopathy of undetermined significance-associated scleromyxoedema
by: Kalgi D Baxi, et al.
Published: (2019-01-01)

Genome-wide meta-analysis of monoclonal gammopathy of undetermined significance (MGUS) identifies risk loci impacting IRF-6
by: Alyssa Clay-Gilmour, et al.
Published: (2022-04-01)

Regression of Intermediate-High Risk Monoclonal Gammopathy of Undetermined Significance (MGUS) With Long-term Use of Curcumin: A Case Report
by: Terry Golombick PhD, Dipl Nut, et al.
Published: (2024-03-01)

P950: PRIOR CANCER AND RISK OF MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE (MGUS): A POPULATION-BASED STUDY IN ICELAND AND SWEDEN
by: Sæmundur Rögnvaldsson, et al.
Published: (2023-08-01)

Scleroderma Associated with Monoclonal Gammopathy of Undetermined Significance
by: Dalya M. M. Abdelmaged, et al.
Published: (2022-12-01)

Monoclonal Gammopathy of Undetermined Significance and Neutrophilic Dermatosis
by: Buthaina Al-Musalhi, et al.
Published: (2016-09-01)

Kidney Transplantation and Monoclonal Gammopathy of Undetermined Significance
by: Nabeel Aslam, MD, et al.
Published: (2021-08-01)

Progression from Monoclonal gammopathy of undetermined significance of the immunoglobulin M class (IgM-MGUS) to Waldenstrom Macroglobulinemia is associated with an alteration in lipid metabolism
by: Shahrzad Jalali, et al.
Published: (2021-05-01)

Prevalence of monoclonal gammopathy of undetermined significance (MGUS) at HIV diagnosis in individuals 18–40 years old: a possible HIV indicator condition
by: Bibas Michele, et al.
Published: (2021-05-01)

Autoimmunity, Infections, and the Risk of Monoclonal Gammopathy of Undetermined Significance
by: Aðalbjörg Ýr Sigurbergsdóttir, et al.
Published: (2022-04-01)

Penile Tuberculosis Associated with Monoclonal Gammopathy of Undetermined Significance
by: Wilfred C.H. Wu, et al.
Published: (2006-01-01)

Contributions of the bone microenvironment to monoclonal gammopathy of undetermined significance pathogenesis
by: Gámez, B, et al.
Published: (2018)

Seek and ye shall find: monoclonal gammopathy of undetermined significance
by: Luz Tarín-Arzaga, et al.
Published: (2023-04-01)

Monoclonal Gammopathy of Undetermined Significance Disguised as Chronic Neutrophilic Leukemia
by: Monique A Hartley-Brown, et al.
Published: (2010-02-01)

Monoclonal Gammopathy of Undetermined Cardiovascular Significance; Current Evidence and Novel Insights
by: Anastasios Tentolouris, et al.
Published: (2023-12-01)

Identifying monoclonal gammopathy of undetermined significance from electronic health records
by: Hilary C. Tanenbaum, et al.
Published: (2023-03-01)

Xanthogranuloma necrobioticum in the course of monoclonal gammopathy of undetermined significance and idiopathic neutropenia
by: Urszula Maińska, et al.
Published: (2023-04-01)

Geographic Prevalence Patterns and Modifiable Risk Factors for Monoclonal Gammopathy of Undetermined Significance
by: Karina P. Verma, et al.
Published: (2023-11-01)

Immunoglobulin abnormalities and monoclonal gammopathy of undetermined significance in uninfected and HIV-infected men
by: Kyle Robert, et al.
Published: (2010-10-01)

Autoimmune retinopathy associated with monoclonal gammopathy of undetermined significance: a case report
by: Emily A. Eton, et al.
Published: (2020-04-01)

Characterization of monoclonal gammopathy of undetermined significance by calorimetric analysis of blood serum proteome.
by: Francisca Barceló, et al.
Published: (2015-01-01)

Coexistence of Prefibrotic Myelofibrosis with Monoclonal Gammopathy of Undetermined Significance: A Case Report
by: Omar M. Ismail, et al.
Published: (2021-10-01)

Data quality of the monoclonal gammopathy of undetermined significance diagnosis in a hospital registry
by: Gregersen H, et al.
Published: (2013-08-01)

Noninfectious mixed cryoglobulinaemic glomerulonephritis and monoclonal gammopathy of undetermined significance: a coincidental association?
by: Adam L. Flavell, et al.
Published: (2020-07-01)

Artificial intelligence-enabled screening strategy for drug repurposing in monoclonal gammopathy of undetermined significance
by: Alexander J. Ryu, et al.
Published: (2023-02-01)

Monoclonal Gammopathy of Undetermined Significance with Three Bands on Serum Protein Electrophoresis: An Atypical Presentation
by: Rashmi Rasi Datta, et al.
Published: (2023-06-01)

Distinct Nuclear Organization of Telomeres and Centromeres in Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma
by: Pak Lok Ivan Yu, et al.
Published: (2019-07-01)

Unusual Spherical Bodies in Bone Marrow of a Patient with Monoclonal Gammopathy of Undetermined Significance
by: Habib Moshref Razavi
Published: (2021-06-01)

Predictive Immune Markers for Disease Progression in Multiple Myeloma and Monoclonal Gammopathy of Undetermined Significance
by: İrem Şahver İşgör, et al.
Published: (2022-11-01)

The yin–yang effects of immunity: From monoclonal gammopathy of undetermined significance to multiple myeloma
by: Zhigang Yi, et al.
Published: (2022-07-01)

Intracytoplasmic inclusions in plasma cells: A diagnostic adjunct in monoclonal gammopathy of undetermined significance
by: Smeeta Gajendra, et al.
Published: (2017-01-01)

Living kidney donor with monoclonal gammopathy of undetermined significance: Is it a contraindication for kidney donation?
by: Vinay Rathore, et al.
Published: (2019-01-01)

Differences in Hospital, Emergency Room and Outpatient Visits Among Adults With and Without Monoclonal Gammopathy of Undetermined Significance
by: Maira A. Castañeda-Avila PhD, et al.
Published: (2022-09-01)